New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)
- 14 April 2023
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 24 (6) , 667-679
Abstract
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated vascular sarcoma. EHE can have different clinical presentations from indolent to rapiKeywords
This publication has 35 references indexed in Scilit:
- Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of MedicineCase Reports in Gastrointestinal Medicine, 2015
- Metastatic Hepatic Epithelioid Hemangio-Endothelioma: Long-Term Response to Sunitinib MalateOncology Research and Treatment, 2014
- Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendotheliomaGenes, Chromosomes and Cancer, 2013
- Sorafenib in patients with progressive epithelioid hemangioendotheliomaCancer, 2013
- Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer PatientsClinical Cancer Research, 2012
- Efficacy of Rapamycin for Refractory Hemangioendotheliomas in Maffucci's SyndromeJournal of Clinical Oncology, 2012
- Clinical Patterns and Outcome in Epithelioid Hemangioendothelioma With or Without Pulmonary InvolvementChest, 2011
- A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sitesGenes, Chromosomes and Cancer, 2011
- Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the LiteratureThe Annals of Thoracic Surgery, 2006
- Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case reportRespirology, 2006